EMEA-001915-PIP01-15-M03
Key facts
| Invented name |
Waylivra
|
| Active substance |
Volanesorsen
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0131/2021
|
| PIP number |
EMEA-001915-PIP01-15-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of familial chylomicronemia syndrome
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Akcea Therapeutics
Tel. +1 6172070202 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|